BiotechTubeBiotechTube
Home/4TEEN4 Pharmaceuticals/Dr. Chris Springer
DC

Dr. Chris Springer

Chief Operating Officer (COO)

4TEEN4 Pharmaceuticals

Therapeutic Areas

Critical CareCardiovascularIntensive Care Medicine

4TEEN4 Pharmaceuticals Pipeline

DrugIndicationPhase
invobenitug (procizumab)Cardiogenic Shock (patients with elevated cDPP3)Phase 1b/2a

Leadership Team at 4TEEN4 Pharmaceuticals

DA
Dr. Andreas Bergmann
Chief Executive Officer (CEO)
DK
Dr. Karine Bourgeois
Chief Scientific Officer (CSO)
PM
Prof. Mahir Karakas
Chief Medical Officer (CMO)
DJ
Dr. Joachim Struck
Chief Research Officer (CRO)
DK
Dr. Kilian von Seldeneck
Chief Financial Officer (CFO)
View full 4TEEN4 Pharmaceuticals profile